| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +1.5% |
| R&D Expense | $58.9M | +4.5% |
| SG&A Expense | $30.6M | +12.9% |
| Operating Income | -$88.0M | -7.3% |
| Pre-tax Income | -$89.4M | -10.2% |
| Income Tax | -$1.8M | -1456.8% |
| Net Income | -$87.6M | -8.1% |
| EPS (Basic) | -$2.00 | -5.3% |
| EPS (Diluted) | -$2.00 | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.9M | -17.1% |
| Short-term Investments | $127.0M | -14.1% |
| Accounts Receivable | $61K | -82.9% |
| Current Assets | $179.0M | -15.5% |
| Total Assets | $219.1M | -13.2% |
| Current Liabilities | $15.1M | +20.4% |
| Long-term Debt | $35.0M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.3M | +3.3% |
| Capital Expenditures | $2.1M | +43.7% |
| Investing Cash Flow | $23.1M | -38.9% |
| Financing Cash Flow | $40.7M | — |
| Free Cash Flow | -$75.4M | +2.3% |
| Total Liabilities |
| $56.8M |
| +173.1% |
| Stockholders' Equity | $162.2M | -29.9% |